Andrew J. Fromkin, Director at Immunovant, Inc. (IMVT), sold 221,951 shares at $32.64 ($7.4M) on 2026-05-28, disclosed to the SEC on 2026-05-29.
Open-market sale of $7.4M IMVT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.64 | 11,483 | $375K | 5.0% |
| 2 | $33.56 | 210,468 | $7.1M | 95.0% |
| Total | $33.51 avg | 221,951 | $7.4M | 100% |
| Filing → |
| IMVT | SELL | 2023-12-05 | $981K | — | Filing → |
| IMVT | BUY | 2021-08-11 | $43K | — | Filing → |